1. Smart Allocation of Experimental Groups and N-numbers
If budget, time, and personnel were infinite, you could simply follow theoretically ideal experimental designs. In the real world, however, we face various constraints—the most significant in microarray and RNA-Seq often being the budget. Since the sample sizes in omics experiments are usually far smaller than what classical statistics demand, blindly following statistical requirements is often impractical.
We sometimes see datasets where technical replicates are measured three times for every single experimental group. However, the "replicates" required for statistical testing are biological replicates. Technical replicates are meant to evaluate the precision of the measurement system itself, not to power your statistical tests. Therefore, it is unnecessary to perform them for every group.
Furthermore, in large-scale experiments producing many samples, batch effects are inevitable. It is essential to incorporate strategies for handling batch effects into your design, rather than just focusing on the N-number. Without this, you risk spending a massive budget to increase samples only to reach a "catastrophic" result where no clear conclusion can be drawn.
From our analysis experience, it is decisively more important to allocate experimental groups while making biological inferences. At the same time, you must anticipate the demands of future peer reviewers. Subio’s extensive experience can help you find the perfect "sweet spot" and balanced compromise.
2. Assess Your Methods Before Committing
Researchers with less experience in omics often place excessive trust in a measurement system. Information from conferences, colleagues, or manufacturers is almost always biased—do not take it at face value. A cautious approach—verifying whether your chosen method meets your expectations or falls short—will save you vast amounts of time and money.
Subio’s Data Analysis Service can be utilized for this very purpose of assessment . By analyzing actual research data, you can visualize exactly what kind of output you will get, providing vital clues for refining your experimental design. Even if this assessment requires a small upfront investment, it is an expenditure that more than pays for itself in the long run.
3. Build Risk Mitigation into Your Design
A common oversight when planning is forgetting that experiments do not always succeed. Failure is a part of research. While it’s natural to want to avoid risk, you cannot eliminate it entirely. The key is to select risks to address based on two criteria: (1) How likely is the failure? and (2) How severe is the impact?
Anyone can imagine (2), but (1) requires deep experience in data analysis. Moreover, the likely pitfalls differ depending on whether you are doing the experiments in-house or outsourcing them. Subio provides specific countermeasures based on our extensive knowledge of these common failures.
Risk mitigation is not free; it often requires allocating samples, so decisions must be made based on cost-effectiveness. On the other hand, some measures cost nothing. For example, how you label your samples or how you place your order with a service provider can significantly reduce risk without any extra cost. By integrating measures of all sizes, you can build a robust experimental design that minimizes the impact of unforeseen events.
At Subio, we provide expert advice on experimental design as part of our Data Analysis Service.